Press monitoring
First genetically-engineered malaria vaccine to enter human trials
30.7.2009 | Press monitoring
Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease. The vaccine, developed in collaboration with researchers from the US, Japan and Canada, will be trialled in humans from early next year.
Skin-like Tissue Developed from Human Embryonic Stem Cells
29.7.2009 | Press monitoring
Dental and tissue engineering researchers at Tufts University School of Dental Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have harnessed the pluripotency of human embryonic stem cells (hESC) to generate complex, multilayer tissues that mimic human skin and the oral mucosa (the moist tissue that lines the inside of the...
Bacterial Computers: Genetically Engineered Bacteria Have Potential To Solve Complicated Mathematical Problems
28.7.2009 | Press monitoring
US researchers have created 'bacterial computers' with the potential to solve complicated mathematics problems. The findings of the research demonstrate that computing in living cells is feasible, opening the door to a number of applications. The second-generation bacterial computers illustrate the feasibility of extending the approach to other...
Human Cells Secrete Cancer-Killing Protein, UK Study Finds
27.7.2009 | Press monitoring
Human cells are able to secrete a cancer-killing protein, scientists at the University of Kentucky's Markey Cancer Center have found.
Tires made from trees – better, cheaper, more fuel efficient
26.7.2009 | Press monitoring
Automobile owners around the world may some day soon be driving on tires that are partly made out of trees – which could cost less, perform better and save on fuel and energy.
New windows opened on cell-to-cell interactions
25.7.2009 | Press monitoring
Applying biological molecules from cell membranes to the surfaces of artificial materials is opening peepholes on the very basics of cell-to-cell interaction.
Common cold virus efficiently delivers corrected gene to cystic fibrosis cells
24.7.2009 | Press monitoring
Scientists have worked for 20 years to perfect gene therapy for the treatment of cystic fibrosis, which causes the body to produce dehydrated, thicker-than-normal mucus that clogs the lungs and leads to life threatening infections.
New method may accelerate drug discovery for difficult diseases like Parkinson’s
23.7.2009 | Press monitoring
Whitehead Institute scientists have developed a rapid, inexpensive drug-screening method that could be used to target diseases that until now have stymied drug developers, such as Parkinson’s disease.
New Information About DNA Repair Mechanism Could Lead To Better Cancer Drugs
22.7.2009 | Press monitoring
Researchers at Washington University School of Medicine in St. Louis have shed new light on a process that fixes breaks in the genetic material of the body's cells. Their findings could lead to ways of enhancing chemotherapy drugs that destroy cancer cells by damaging their DNA.
Researchers develop process for 'surgical' genetic changes
21.7.2009 | Press monitoring
Research led by scientists at Iowa State University's Plant Sciences Institute has resulted in a process that will make genetic changes in plant genes much more efficient, practical and safe.
